Supplementary Material for: NCOA3 Loss Disrupts Molecular Signature of Chondrocytes and Promotes Posttraumatic Osteoarthritis Progression

Bin Zhang, Zixing Li, Wenhui Wang, Jian Guo, S. Kang, Simin Liu, Hongliang Li, D. Wang, Xingrong QiFigshare 2018 · DOI · OpenAlex

Abstract

<b><i>Background/Aims:</i></b> Osteoarthritis (OA) is the most common joint disease. Recently, a novel variant near the nuclear receptor coactivator 3 (<i>NCOA3</i>) has been identified in association with greater risk of developing OA. However, how NCOA3 is regulated in chondrocytes and involved in OA pathogenesis remain elusive. <b><i>Methods:</i></b> The expression and DNA methylation of <i>NCOA3</i> in knee OA cartilage and <i>in vitro</i> dedifferentiated chondrocytes with or without rs6094710 SNP were analyzed by qRT-PCR, immunoblotting, methylation-specific PCR and bisulfite sequencing. NCOA3 was depleted by siRNA or shRNA or inhibited by a chemical inhibitor to assess its role in chondrocyte dedifferentiation or OA pathogenesis in posttraumatic OA animal model established by cruciate ligament transection surgery. <b><i>Results:</i></b> We found that compared with normal counterparts, samples with rs6094710 SNP failed to upregulate NCOA3. Further evidence associated this phenotype with DNMT1-mediated hypermethylation in gene promoter region. Moreover, we showed that NCOA3 maintained the molecular signature of chondrocytes dedifferentiating <i>in vitro</i> or exposed to IL-1β, nevertheless, NCOA3 appeared dispensable for preventing OA initiation, since NCOA3 loss did not trigger OA in young mice. Instead, NCOA3 loss promoted posttraumatic OA progression, and in parallel, enhanced NF-κB activation. Finally, the promoted posttraumatic OA progression was significantly retarded when administrated with NF-κB pathway inhibitor, suggesting that NCOA3 lose promotes posttraumatic OA at least partially by enhancing NF-κB activation. <b><i>Conclusion:</i></b> Thus, our findings indicate a critical role of NCOA3 in chondrocytes, and imply that manipulating NCOA3 might present a potential therapeutic approach to interfere OA progression.
BibTeX
@inproceedings{zhang2018supplementary,
  author = {Bin Zhang and Zixing Li and Wenhui Wang and Jian Guo and S. Kang and Simin Liu and Hongliang Li and D. Wang and Xingrong Qi},
  title = {{Supplementary Material for: NCOA3 Loss Disrupts Molecular Signature of Chondrocytes and Promotes Posttraumatic Osteoarthritis Progression}},
  booktitle = {Figshare},
  year = {2018},
  doi = {10.6084/m9.figshare.7140149},
}

Loading related content...

Figure